Comparison of benefits of high-dose steroid Administration and normal-dose Steroid in combination with antiviral agentsin in the Treatment of Bell's Palsy
Not Applicable
Recruiting
- Conditions
- Bell's Palsy
- Registration Number
- JPRN-UMIN000025128
- Lead Sponsor
- Department of Otolaryngology, Head and Neck Surgery, Yamagata University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
1.recurrent palsy 2.auricular redness or strong otalgia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The patients are divided into two groups based on the treatment protocols with:Group 1 receiving a high dose of PSL at 200 mg/day + Hespander + Mannitol intravenously; Group 2 receiving a normal dose of PSL at 60 mg/day orally + the antiviral agent VACV at 3000 mg/day. We assess complete recovery as an HB grade of grade I at 1 year.
- Secondary Outcome Measures
Name Time Method